On Oct. 16, 2006, the Cancer Genome Atlas program, created by National Cancer Institute and the National Human Genome Research Institute (NHGRI), will accelerate understanding of the molecular basis of cancer through the application of genome analysis technologies. NIH today announced another two of the components of The Cancer Genome Atlas (TCGA) Pilot Project, a 3-year, $100 million collaboration to test the feasibility of using large-scale genome analysis technologies to identify important genetic changes involved in cancer. Lung, brain (glioblastoma), and ovarian cancers were chosen as the tumors for study by TCGA Pilot Project.